Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 77 (4) , 457-468
Abstract
No abstract availableKeywords
Funding Information
- Soteria Medical
This publication has 31 references indexed in Scilit:
- Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2European Urology, 2019
- Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical StudyEuropean Urology, 2019
- Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic studyThe Lancet Oncology, 2019
- Magnetic resonance imaging of the prostate at 1.5 versus 3.0 T: A prospective comparison study of image qualityEuropean Journal of Radiology, 2017
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2European Urology, 2016
- Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the LiteratureEuropean Urology, 2015
- Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysisEuropean Urology, 2015
- The impact of gradient strength on in vivo diffusion MRI estimates of axon diameterNeuroImage, 2015
- Image Artifacts on Prostate Diffusion-weighted Magnetic Resonance ImagingAcademic Radiology, 2013
- ESUR prostate MR guidelines 2012European Radiology, 2012